In today’s recent session, 2.59 million shares of the Bright Minds Biosciences Inc (NASDAQ:DRUG) have been traded, and its beta is 1.24. Most recently the company’s share price was $1.17, and it changed around $0.16 or 15.84% from the last close, which brings the market valuation of the company to $5.22M. DRUG at last check was trading at a discount to its 52-week high of $2.64, offering almost -125.64% off that amount. The share price’s 52-week low was $0.93, which indicates that the recent value has risen by an impressive 20.51% since then. We note from Bright Minds Biosciences Inc’s average daily trading volume that its 10-day average is 13190.0 shares, with the 3-month average coming to 22.53K.
Bright Minds Biosciences Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended DRUG as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Bright Minds Biosciences Inc is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bright Minds Biosciences Inc (NASDAQ:DRUG) trade information
Instantly DRUG has been showing a green trend so far today with a performance of 15.84% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7500 on recent trading dayincreased the stock’s daily price by 33.14%. The company’s shares are currently down -18.18% year-to-date, but still up 14.69% over the last five days. On the other hand, Bright Minds Biosciences Inc (NASDAQ:DRUG) is -2.50% down in the 30-day period. We can see from the shorts that 72316.0 shares have been sold at a short interest cover period of 1.7 day(s).
Bright Minds Biosciences Inc (DRUG) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -137.36%.
DRUG Dividends
Bright Minds Biosciences Inc’s next quarterly earnings report is expected to be released in September.
Bright Minds Biosciences Inc (NASDAQ:DRUG)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 35.48% of Bright Minds Biosciences Inc shares, and 4.42% of them are in the hands of institutional investors. The stock currently has a share float of 6.86%.
The former held 180.99 shares worth $0.21 million, making up 4.08% of all outstanding shares.
